185 related articles for article (PubMed ID: 23855994)
1. The development of a clinical screening instrument for tumour predisposition syndromes in childhood cancer patients.
Hopman SM; Merks JH; de Borgie CA; Aalfs CM; Biesecker LG; Cole T; Eng C; Legius E; Maher ER; van Noesel MM; Verloes A; Viskochil DH; Wagner A; Weksberg R; Caron HN; Hennekam RC
Eur J Cancer; 2013 Oct; 49(15):3247-54. PubMed ID: 23855994
[TBL] [Abstract][Full Text] [Related]
2. Validation of a clinical screening instrument for tumour predisposition syndromes in patients with childhood cancer (TuPS): protocol for a prospective, observational, multicentre study.
Postema FA; Hopman SM; de Borgie CA; Hammond P; Hennekam RC; Merks JH; ; Aalfs CM; Anninga JK; Berger LP; Bleeker FE; de Bont ES; de Borgie CA; Dommering CJ; van Eijkelenburg NK; Hammond P; Hennekam RC; van den Heuvel-Eibrink MM; Hopman SM; Jongmans MC; Kors WA; Letteboer TG; Loeffen JL; Merks JH; Olderode-Berends MJ; Postema FA; Wagner A;
BMJ Open; 2017 Jan; 7(1):e013237. PubMed ID: 28110285
[TBL] [Abstract][Full Text] [Related]
3. Genomic approaches to accelerate cancer interception.
Beane J; Campbell JD; Lel J; Vick J; Spira A
Lancet Oncol; 2017 Aug; 18(8):e494-e502. PubMed ID: 28759388
[TBL] [Abstract][Full Text] [Related]
4. A clinical screening tool to detect genetic cancer predisposition in pediatric oncology shows high sensitivity but can miss a substantial percentage of affected children.
Friedrich UA; Bienias M; Zinke C; Prazenicova M; Lohse J; Jahn A; Menzel M; Langanke J; Walter C; Wagener R; Brozou T; Varghese J; Dugas M; Erlacher M; Schröck E; Suttorp M; Borkhardt A; Hauer J; Auer F
Genet Med; 2023 Aug; 25(8):100875. PubMed ID: 37149759
[TBL] [Abstract][Full Text] [Related]
5. Structural genome variations in individuals with childhood cancer and tumour predisposition syndromes.
Hopman S; Merks J; Eussen H; Douben H; Snijder S; Hennekam R; de Klein A; Caron H
Eur J Cancer; 2013 Jun; 49(9):2170-8. PubMed ID: 23473611
[TBL] [Abstract][Full Text] [Related]
6. Childhood tumours with a high probability of being part of a tumour predisposition syndrome; reason for referral for genetic consultation.
Postema FAM; Hopman SMJ; Aalfs CM; Berger LPV; Bleeker FE; Dommering CJ; Jongmans MCJ; Letteboer TGW; Olderode-Berends MJW; Wagner A; Hennekam RC; Merks JHM
Eur J Cancer; 2017 Jul; 80():48-54. PubMed ID: 28544908
[TBL] [Abstract][Full Text] [Related]
7. Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and Hematology.
Ripperger T; Bielack SS; Borkhardt A; Brecht IB; Burkhardt B; Calaminus G; Debatin KM; Deubzer H; Dirksen U; Eckert C; Eggert A; Erlacher M; Fleischhack G; Frühwald MC; Gnekow A; Goehring G; Graf N; Hanenberg H; Hauer J; Hero B; Hettmer S; von Hoff K; Horstmann M; Hoyer J; Illig T; Kaatsch P; Kappler R; Kerl K; Klingebiel T; Kontny U; Kordes U; Körholz D; Koscielniak E; Kramm CM; Kuhlen M; Kulozik AE; Lamottke B; Leuschner I; Lohmann DR; Meinhardt A; Metzler M; Meyer LH; Moser O; Nathrath M; Niemeyer CM; Nustede R; Pajtler KW; Paret C; Rasche M; Reinhardt D; Rieß O; Russo A; Rutkowski S; Schlegelberger B; Schneider D; Schneppenheim R; Schrappe M; Schroeder C; von Schweinitz D; Simon T; Sparber-Sauer M; Spix C; Stanulla M; Steinemann D; Strahm B; Temming P; Thomay K; von Bueren AO; Vorwerk P; Witt O; Wlodarski M; Wössmann W; Zenker M; Zimmermann S; Pfister SM; Kratz CP
Am J Med Genet A; 2017 Apr; 173(4):1017-1037. PubMed ID: 28168833
[TBL] [Abstract][Full Text] [Related]
8. Protocol for a comprehensive prospective cohort study of trio-based whole-genome sequencing for underlying cancer predisposition in paediatric and adolescent patients newly diagnosed with cancer: the PREDICT study.
Fuentes Bolanos NA; Padhye B; Daley M; Hunter J; Hetherington K; Warby M; Courtney E; Kirk J; Josephi-Taylor S; Chen Y; Alvaro F; Barlow-Stewart K; Wong-Erasmus M; Barahona P; Ajuyah P; Altekoester AK; Tyrrell VJ; Lau LMS; Wakefield C; Sylvester D; Tucker K; Pinese M; Dalla Pozza L; O'Brien TA
BMJ Open; 2023 May; 13(5):e070082. PubMed ID: 37253493
[TBL] [Abstract][Full Text] [Related]
9. Genetic testing and tumor surveillance for children with cancer predisposition syndromes.
Rao A; Rothman J; Nichols KE
Curr Opin Pediatr; 2008 Feb; 20(1):1-7. PubMed ID: 18197032
[TBL] [Abstract][Full Text] [Related]
10. Genetic predisposition to cancers in children and adolescents.
Nakano Y; Rabinowicz R; Malkin D
Curr Opin Pediatr; 2023 Feb; 35(1):55-62. PubMed ID: 36354292
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center study.
Postema FAM; Hopman SMJ; de Borgie CAJM; Aalfs CM; Anninga JK; Berger LPV; Bleeker FE; Dommering CJ; van Eijkelenburg NKA; Hammond P; van den Heuvel-Eibrink MM; Hol JA; Kors WA; Letteboer TGW; Loeffen JLCM; Meijer L; Olderode-Berends MJW; Wagner A; Hennekam RC; Merks JHM
Fam Cancer; 2021 Oct; 20(4):263-271. PubMed ID: 33686467
[TBL] [Abstract][Full Text] [Related]
12. Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood.
Achatz MI; Porter CC; Brugières L; Druker H; Frebourg T; Foulkes WD; Kratz CP; Kuiper RP; Hansford JR; Hernandez HS; Nathanson KL; Kohlmann WK; Doros L; Onel K; Schneider KW; Scollon SR; Tabori U; Tomlinson GE; Evans DGR; Plon SE
Clin Cancer Res; 2017 Jul; 23(13):e107-e114. PubMed ID: 28674119
[TBL] [Abstract][Full Text] [Related]
13. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.
Goudie C; Witkowski L; Cullinan N; Reichman L; Schiller I; Tachdjian M; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Clark ME; Clinton C; Coltin H; Felton K; Fernandez CV; Fleming AJ; Fuentes-Bolanos N; Gibson P; Grant R; Hammad R; Harrison LW; Irwin MS; Johnston DL; Kane S; Lafay-Cousin L; Lara-Corrales I; Larouche V; Mathews N; Meyn MS; Michaeli O; Perrier R; Pike M; Punnett A; Ramaswamy V; Say J; Somers G; Tabori U; Thibodeau ML; Toupin AK; Tucker KM; van Engelen K; Vairy S; Waespe N; Warby M; Wasserman JD; Whitlock JA; Sinnett D; Jabado N; Nathan PC; Shlien A; Kamihara J; Deyell RJ; Ziegler DS; Nichols KE; Dendukuri N; Malkin D; Villani A; Foulkes WD
JAMA Oncol; 2021 Dec; 7(12):1806-1814. PubMed ID: 34617981
[TBL] [Abstract][Full Text] [Related]
14. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
15. Pediatric Cancer Predisposition and Surveillance: An Overview, and a Tribute to Alfred G. Knudson Jr.
Brodeur GM; Nichols KE; Plon SE; Schiffman JD; Malkin D
Clin Cancer Res; 2017 Jun; 23(11):e1-e5. PubMed ID: 28572261
[TBL] [Abstract][Full Text] [Related]
16. Predisposition to cancer in children and adolescents.
Kratz CP; Jongmans MC; Cavé H; Wimmer K; Behjati S; Guerrini-Rousseau L; Milde T; Pajtler KW; Golmard L; Gauthier-Villars M; Jewell R; Duncan C; Maher ER; Brugieres L; Pritchard-Jones K; Bourdeaut F
Lancet Child Adolesc Health; 2021 Feb; 5(2):142-154. PubMed ID: 33484663
[TBL] [Abstract][Full Text] [Related]
17. Recognition and management of childhood cancer syndromes: a systems approach.
Clericuzio CL
Am J Med Genet; 1999 Jun; 89(2):81-90. PubMed ID: 10559762
[TBL] [Abstract][Full Text] [Related]
18. Initiation of universal tumor screening for Lynch syndrome in colorectal cancer patients as a model for the implementation of genetic information into clinical oncology practice.
Cohen SA; Laurino M; Bowen DJ; Upton MP; Pritchard C; Hisama F; Jarvik G; Fichera A; Sjoding B; Bennett RL; Naylor L; Jacobson A; Burke W; Grady WM
Cancer; 2016 Feb; 122(3):393-401. PubMed ID: 26480326
[TBL] [Abstract][Full Text] [Related]
19. [Germ line mutations causing paediatric cancer predisposition syndromes are common in children and adolescents with cancer].
Stoltze UK; Byrjalsen A; Hjalgrim LL; Wahlberg A; Gupta R; Gerdes AM; Wadt K; Schmiegelow K
Ugeskr Laeger; 2018 Apr; 180(17):. PubMed ID: 29717702
[TBL] [Abstract][Full Text] [Related]
20. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
O'Neill RS; Emmanuel S; Williams D; Stoita A
World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
